SHANGHAI, China & JERSEY CITY, N.J.--(BUSINESS WIRE)--Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) today announced that the European Medicines Agency (EMA) has validated the ...
Organon (OGN) closed the latest trading day at $15.39, indicating a -1.35% change from the previous session's end. The stock's performance was behind the S&P 500's daily gain of 0.08%. Elsewhere ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback